Lattice Biologics (TSXV:LBL.H) Days Inventory : 0.00 (As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Lattice Biologics's Average Total Inventories for the three months ended in Jun. 2021 was C$0.00 Mil. Lattice Biologics's Cost of Goods Sold for the three months ended in Jun. 2021 was C$0.00 Mil.

The historical rank and industry rank for Lattice Biologics's Days Inventory or its related term are showing as below:

TSXV:LBL.H's Days Inventory is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 193.045
* Ranked among companies with meaningful Days Inventory only.

Lattice Biologics's Days Inventory declined from Jun. 2020 (162.33) to Jun. 2021 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lattice Biologics Days Inventory Historical Data

The historical data trend for Lattice Biologics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Days Inventory Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Days Inventory

Get a 7-Day Free Trial

270.95

353.07

958.81

317.08

154.68

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Days Inventory	Get a 7-Day Free Trial															162.33	87.12	205.60	188.38	-

Competitive Comparison of Lattice Biologics's Days Inventory

For the Medical Devices subindustry, Lattice Biologics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Days Inventory falls into.

Lattice Biologics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lattice Biologics's Days Inventory for the fiscal year that ended in Sep. 2020 is calculated as

	Days Inventory (A: Sep. 2020 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Sep. 2019 )	+	Total Inventories (A: Sep. 2020 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2020 )	*	Days in Period
=	( (0.931	+	0.687)	/	2 )	/	1.909	*	365
=	0.809					/	1.909	*	365
=	154.68

Lattice Biologics's Days Inventory for the quarter that ended in Jun. 2021 is calculated as:

	Days Inventory (Q: Jun. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2021 )	+	Total Inventories (Q: Jun. 2021 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Lattice Biologics (TSXV:LBL.H) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lattice Biologics's Inventory Turnover for the three months ended in Jun. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lattice Biologics's Inventory to Revenue for the three months ended in Jun. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Lattice Biologics Days Inventory Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines